LAV, Boyu & HongShan Re-up in Gene Therapy Play
09 Aug 2024
US$ 19.00
Lilly Asia Ventures, Boyu Capital, Zoo Capital, HongShan and New Alliance Capital have made a follow-on investment ......
Related Publications
After a sweeping consolidation of legacy government-sponsored venture capital fund management firms in Malaysia to come...
Subscribers’ Weekly for the week ending 16 Jan 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.